Thursday broker round-up
4th Dec 2014 08:46
Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan
Read moreFTSE 250 movers: Supergroup rises as Numis reaffirms rating
6th Nov 2014 15:45
Supergroup rose after Numis Securities reaffirmed its 'hold' rating on the stock, with a target price of 1,100p which would suggest a potential upside of 41.21% from the stock's previous close. Since 31 October, three other analysts firms, Berenberg, Investec and Cantor Fitzgerald Europe, reiterated
Read moreLondon midday: UK stocks hit by Ebola worries, travel stocks fall
24th Oct 2014 11:33
UK stocks fell on Friday morning after the FTSE 100 hit its highest level in two weeks the previous session, with investors treading cautiously after another reported case of Ebola in the States. The Footsie was down 0.3% at 6,397 by midday, but had pared losses after hitting a low of 6,374.24 early
Read moreLondon open: Ebola fears hit UK stocks after NY doctor tests positive for virus
24th Oct 2014 08:35
UK stocks experienced some selling pressure on Friday morning after rising to their highest in two weeks, as renewed concerns about the spread of Ebola weighed on market sentiment. The FTSE 100 was down 0.6% at 6,380 in early deals, after having closed Thursday's session at 6,419.15, its highest fin
Read moreHikma Pharmaceuticals receives warning letter from FDA
24th Oct 2014 07:38
Pharmaceuticals group Hikma received a warning letter from the US Food and Drug Administration overnight relating to its manufacturing facility in Portugal. The agency raised issues related to investigations and environmental monitoring at the facility. The warning is not expected to impact the manu
Read moreLondon pre-open: FTSE to open lower ahead of German data, UK GDP
24th Oct 2014 07:31
Reports of a new case of Ebola in the States, together with upcoming EU bank stress test results and German consumer confidence figures, are all set to provide a drag on UK markets at Friday's opening bell. City sources predict the FTSE 100 will open around 20 points lower than Thursday's close of 6
Read moreHikma non-exec sells 7,000 shares
10th Oct 2014 16:25
Ronald Goode, a non-executive director at Hikma Pharmaceuticals, on Thursday traded in £129,640-worth of shares in the group. The move proved a fortunate one for Goode, as the company's share price fell more than 3% in Friday's trading after the group learned that distribution of its colchicine 0.6
Read moreFTSE 250 movers: Telecom Plus climbs as oil stocks slide
10th Oct 2014 15:13
Utility services group Telecom Plus said it is happy with market expectations for the full year after strong organic growth in the first half, causing shares to surge on Friday. The company said that the strong growth in both customers and service numbers seen at the start of the year accelerated in
Read moreHikma Pharmaceuticals drug put under restraining order
10th Oct 2014 12:29
Distribution of Hikma Pharmaceuticals' food and drug administration (FDA) approved colchicine 0.6mg capsules has been put under a temporary restraining order, the company announced on Friday. The order was granted to Takeda Pharmaceuticals, with litigation between the two companies expected to conti
Read moreFriday broker round-up UPDATE
26th Sep 2014 08:38
Balfour Beatty: Deutsche Bank ups target price from 245p to 270p upgrading to buy. Betfair: JP Morgan raises target price from 1050p to 1175p leaving its neutral rating unchanged. British Land: Societe Generale upgrades to buy with a target price of 780p. Dairy Crest: Investec cuts target price fr
Read moreHikma completes acquisition of Ben Venue manufacturing site
17th Sep 2014 12:12
Hikma Pharmaceuticals announced on Wednesday the completion of the acquisition for the Ben Venture Laboratories’ manufacturing site. Ben Ventures Laboratories is a subsidary of the Boehringer Ingelheim Pharmaceuticals Group. As agreed on 24 July, Hikma has now acquired ownership of all of the
Read moreSector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes
21st Aug 2014 17:48
Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making
Read moreLondon midday: UK stocks advance as investors shrug off weak data
21st Aug 2014 12:01
- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda
Read moreFTSE 250 movers: Ex-divi stocks and Balfour lead index lower
20th Aug 2014 13:57
Berkeley Group, Fidessa Group and Taylor Wimpey all dropped into the red after going ex-dividend on Wednesday. Balfour Beatty was in negative territory after rejecting another merger offer from rival Carillion, saying such a move would not be in shareholders' best interest. Tuesday's offer was the
Read moreHikma revenue lifted by strong injectables performance
20th Aug 2014 09:11
A strong performance by its injectables business helped drive first half revenue growth of 16% at pharmaceuticals manufacturer Hikma. The business delivered a 41% jump in turnover, lifting group revenue from $638m to $738m and the gross margin from 55.3% to 59.8%. A good performance was seen acr
Read more